Cycrin combined with Prempro

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Female Other Serious 5/29/2002 Female 1/3/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/10/2004 Female 1/3/2006 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious Female 1/3/2006 United States
Primary
Secondary
Neoplasm Malignant Other Serious Female 1/11/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/29/2002 Female 1/9/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/10/2004 Female 1/12/2006 United States
Primary
Secondary
Stress Required Intervention 7/10/2000 62 Female 144 lb 1/13/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/1/2002 Female 1/19/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2002 Female 1/24/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/1/1998 Female 1/26/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 1/31/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2001 Female 2/1/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 2/6/2006 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/20/2001 54 Female 503 lb 2/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/1996 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/13/2003 50 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2000 51 Female 145 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/16/2001 49 Female 125 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 7/18/2003 Female 12/23/2005 United States
Primary
Secondary
Menorrhagia Other Serious 3/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/3/2003 60 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/26/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1998 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2004 65 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/3/2002 56 Female 130 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/27/2003 61 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 3/2/2005 53 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 9/9/1997 68 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/10/2001 60 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 2/20/2002 65 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 6/1/2003 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/3/2000 Female 12/23/2005 United States
Primary
Secondary
Transient Ischaemic Attack Other Serious 10/8/2003 63 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/31/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/9/2003 64 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/27/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/10/2001 Female 12/23/2005 United States
Primary
Secondary
Optic Ischaemic Neuropathy Other Serious 8/8/2002 57 Female 2/2/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/25/1999 60 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2003 60 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/15/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/1999 68 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2002 73 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1998 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 3/10/1998 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/10/1998 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/14/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 2/12/2002 Female 12/23/2005 United States
Primary
Secondary
Ovarian Cancer Other Serious 3/31/2003 63 Female 12/23/2005 United States
Primary
Secondary
Drug Ineffective Other Serious 1/25/2002 57 Female 12/23/2005 United States
Primary
Secondary
Myocardial Infarction Other Serious 9/1/1997 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/16/2001 54 Female 170 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/14/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/1996 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/11/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/25/2002 65 Female 180 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 1/21/1999 74 Female 2/7/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 11/11/1997 66 Female 2/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/4/2002 65 Female 142 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/19/2002 71 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/8/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/20/2004 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2002 58 Female 12/23/2005 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/10/2001 54 Female 220 lb 2/10/2006 United States
Primary
Secondary
Cerebrovascular Accident Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/1998 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/16/1999 Female 12/23/2005 United States
Primary
Secondary
Ovarian Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 2/28/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/11/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/27/1999 69 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/14/1999 64 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 7/23/1999 70 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/1997 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/15/2001 74 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 75 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/11/2003 58 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/17/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1982 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/24/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/20/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/2/2000 64 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/10/2002 58 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/31/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2003 57 Female 129 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/5/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/20/2003 65 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/20/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/24/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/25/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1992 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/8/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/15/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 3/15/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1988 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2003 Female 12/23/2005 United States
Primary
Secondary

Drug Data